P3 Health Partners (PIII) Q2 2024 earnings summary

Executive summary

• Platform manages 128,100 lives with 2,900 PCPs across five states and 27 counties, operating a fully delegated risk model in a large, growing Medicare market.

• Q2 2024 revenue rose 15% year-over-year to $379.2 million, driven by a 23% increase in at-risk members and expansion into new counties.

• CEO identified initiatives to enhance Star Ratings, align risk contracts, improve provider network performance, and target sustainable profitability.

• Focus on value-based care, diversified payer mix (no payer >20% of revenue), and strong provider relationships.

• The company operates in the $944 billion Medicare market, with a core focus on the Medicare Advantage segment.

Financial highlights

• Q2 2024 revenue grew 15% year-over-year to $379.2 million, with capitated revenue at $374.3 million.

• Membership increased 23% year-over-year to 128,100, exceeding the low end of full-year guidance.

• Medical margin was $41.1 million ($107 PMPM), down from $50.5 million ($161 PMPM) in Q2 2023.

• Adjusted EBITDA loss for Q2 was $8.8 million, compared to a $0.2 million gain in Q2 2023.

• Gross profit for Q2 2024 was $14.0 million, down from $26.8 million in Q2 2023.

Outlook and guidance

• 2024 guidance: at-risk membership 125,000–135,000, revenue $1.45–$1.55 billion, medical margin $230–$250 million ($165–$175 PMPM), Adjusted EBITDA $20–$40 million.

• Management expects continued operating losses and negative cash flows as it invests in growth and expands its member base.

• Confident in guidance due to revenue recognition policy, medical cost management, and ongoing cost efficiency initiatives, but cautions actual results may differ materially due to risk factors.